As shown in Figures 3(a) and 3(b), CRC patients who were strongly resistin-positive had worse RFS and OS than those who were not strongly resistin-positive, although the data did not support an unequivocal association (P = 0.409 and P = 0.078, respectively). The gene discussed is RETN; the disease is colorectal carcinoma.